"Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia" by Theresa A. Zesiewicz

Contribution to Book

Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia

Proceedings of the American Academy of Neurology Annual Meeting (2011)

Theresa A. Zesiewicz, University of South Florida
Kelly L. Sullivan, Georgia Southern University
J. Farmer
C. Kamp
R. Chen
A. Brocht
S. Bennett
Israt Jahan, University of South Florida
Clifton L. Gooch
Amber M. Miller, University of South Florida
David R. Lynch

Abstract

This conference abstract was published in the Proceedings of the American Academy of Neurology Annual Meeting.

Keywords

Double-blind,
Randomized,
Placebo-controlled,
Pilot study,
Varenicline,
Treatment,
Friedreich's Ataxia,
Chantix®

Disciplines

Epidemiology and
Public Health

Publication Date

April 13, 2011

Citation Information

Theresa A. Zesiewicz, Kelly L. Sullivan, J. Farmer, C. Kamp, et al.. "Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia" Honolulu, HIProceedings of the American Academy of Neurology Annual Meeting (2011)
Available at: http://works.bepress.com/kelly_sullivan/40/